indocyanine green has been researched along with sertraline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Fan, K; Lei, Y; Wang, Z; Xie, S; Yu, Y; Zeng, L; Zhang, S; Zhong, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for indocyanine green and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for indocyanine green and sertraline
| Article | Year |
|---|---|
Sertraline/ICG-loaded liposome for dual-modality imaging and effective chemo-photothermal combination therapy against metastatic clear cell renal cell carcinoma.
Topics: Antineoplastic Agents; Biocompatible Materials; Carcinoma, Renal Cell; Cell Membrane Permeability; Combined Modality Therapy; Drug Compounding; Drug Liberation; Humans; Indocyanine Green; Liposomes; Nanocapsules; Optical Imaging; Photochemotherapy; Sertraline | 2020 |